학술논문
Imatinib Mesylate Reduces Bone Marrow Fibrosis and Overwhelms the Adverse Prognostic Impact of Reticulin Formation in Patients with Chronic Myeloid Leukemia
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15280020